{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:53:23Z","timestamp":1781646803814,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100016003","name":"Istanbul University Cerrahpa\u015fa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016003","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Phosphoglucomutase 3 deficiency (PGM3 deficiency) is a rare congenital disorder of glycosylation classically associated with severe immunodeficiency, skeletal abnormalities, and neurodevelopmental impairment. However, emerging evidence suggests that PGM3 deficiency may also present with attenuated or milder clinical phenotypes. In this study, we describe patients with a novel PGM3 variant exhibiting a less severe immunological and clinical presentation, thereby expanding the known phenotypic spectrum of PGM3 deficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Demographic-data and Wechsler Intelligence Scale for Children profiles were evaluated alongside laboratory data, including complete blood cell counts, lymphocyte subsets, serum immunoglobulin levels, vaccine antibody titers, and lymphocyte cytokine profiles. Whole exome sequencing was conducted, and phospho-flow assays were utilized for the analysis of p-STATs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five patients with a mild form of PGM3 deficiency were described, exhibiting a Hyper-IgE Syndrome phenotype without severe skeletal dysplasia or dysmorphism, with the exception of one patient displaying very mild skeletal dysplasia and three patients exhibiting mild to moderate intellectual disability. All patients demonstrated an increase in Natural Killer T cells and a decrease in B cells, alongside an increase in activated CD4\u2009+\u2009T cells (CD45RO+), a decrease in na\u00efve CD4\u2009+\u2009and CD8\u2009+\u2009T cells (CD45RA+ CCR7+), and an increase in TEMRA CD8\u2009+\u2009T cells (CD45RA+CCR7\u2013). Functional analysis of all patients revealed impaired PGM3 function, as evidenced by decreased surface expression of gp130 and p-STAT3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Defective glycosylation in PGM3 deficiency leads to reduced gp130 expression and attenuated gp130-dependent STAT3 phosphorylation. The resulting cellular features partially overlap with those observed in STAT3 loss-of-function and gp130 deficiency, supporting a shared signaling mechanism while remaining clinically distinct.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10875-026-02012-2","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T02:15:37Z","timestamp":1774750537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Novel Phosphoglucomutase-3 Gene Variant Causing Milder Phenotype in Two Families"],"prefix":"10.1007","volume":"46","author":[{"given":"Betul","family":"Gemici Karaaslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Benamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selami","family":"Ulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezin","family":"Aydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gozde","family":"Yesil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Gezdirici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysun Ayaz","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Nepesov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haluk","family":"Cokugras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yildiz","family":"Camcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akif","family":"Ayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigdem","family":"Aydogmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Marie","family":"Charbonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"Chatila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayca","family":"Kiykim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"issue":"1","key":"2012_CR1","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1146\/annurev-biochem-060608-102511","volume":"80","author":"GW Hart","year":"2011","unstructured":"Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annual review of biochemistry. 2011;80(1):825\u201358.","journal-title":"Annual review of biochemistry"},{"issue":"2","key":"2012_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41436-019-0647-2","volume":"22","author":"J Verheijen","year":"2020","unstructured":"Verheijen J, Tahata S, Kozicz T, Witters P, Morava E. Therapeutic approaches in Congenital Disorders of Glycosylation (CDG) involving N-linked glycosylation: an update. Genetics in Medicine. 2020;22(2):268\u201379.","journal-title":"Genetics in Medicine"},{"issue":"5","key":"2012_CR3","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jaci.2014.02.013","volume":"133","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Yu X, Ichikawa M, Lyons JJ, Datta S, Lamborn IT, et al. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. Journal of Allergy and Clinical Immunology. 2014;133(5):1400-9. e5.","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"8","key":"2012_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082218","volume":"19","author":"V Citro","year":"2018","unstructured":"Citro V, Cimmaruta C, Monticelli M, Riccio G, Hay Mele B, Cubellis MV, et al. The analysis of variants in the general population reveals that PMM2 is extremely tolerant to missense mutations and that diagnosis of PMM2-CDG can benefit from the identification of modifiers. International journal of molecular sciences. 2018;19(8):2218.","journal-title":"International journal of molecular sciences"},{"key":"2012_CR5","unstructured":"5. Sassi A, Lazaroski S, Wu G, Haslam SM, Fliegauf M, Mellouli F, et al. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. Journal of allergy and clinical immunology. 2014;133(5):1410-9. e13."},{"issue":"1","key":"2012_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajhg.2014.05.007","volume":"95","author":"A Stray-Pedersen","year":"2014","unstructured":"Stray-Pedersen A, Backe PH, Sorte HS, M\u00f8rkrid L, Chokshi NY, Erichsen HC, et al. PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia. The American Journal of Human Genetics. 2014;95(1):96\u2013107.","journal-title":"The American Journal of Human Genetics."},{"issue":"1","key":"2012_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jaci.2015.07.047","volume":"137","author":"JM Bernth-Jensen","year":"2016","unstructured":"Bernth-Jensen JM, Holm M, Christiansen M. Neonatal-onset T\u2009\u2212\u2009B\u2212 NK+ severe combined immunodeficiency and neutropenia caused by mutated phosphoglucomutase 3. Journal of Allergy and Clinical Immunology. 2016;137(1):321\u20134.","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"2012_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/pai.13398","volume":"32","author":"A Garc\u00eda-Garc\u00eda","year":"2021","unstructured":"Garc\u00eda-Garc\u00eda A, Buendia Arellano M, Dey\u00e0-Mart\u00ednez \u00c0, Lozano Blasco J, Serrano M, Van Den Rym A, et al. Novel PGM3 compound heterozygous variants with IgE-related dermatitis, lymphopenia, without syndromic features. Pediatric Allergy and Immunology. 2021;32(3):566\u201375.","journal-title":"Pediatric Allergy and Immunology."},{"issue":"1","key":"2012_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10875-019-00693-6","volume":"40","author":"C Ittiwut","year":"2020","unstructured":"Ittiwut C, Manuyakorn W, Tongkobpetch S, Benjaponpitak S, Fisher MR, Milner JD, et al. Compound heterozygous PGM3 mutations in a Thai patient with a specific antibody deficiency requiring monthly IVIG infusions. Journal of clinical immunology. 2020;40(1):227\u201331.","journal-title":"Journal of clinical immunology."},{"issue":"2","key":"2012_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.clim.2015.10.002","volume":"161","author":"KE Lundin","year":"2015","unstructured":"Lundin KE, Hamasy A, Backe PH, Moens LN, Falk-S\u00f6rqvist E, Elgst\u00f8en KB, et al. Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene. Clinical Immunology. 2015;161(2):366\u201372.","journal-title":"Clinical Immunology."},{"issue":"1","key":"2012_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12887-018-1258-9","volume":"18","author":"KE Lundin","year":"2018","unstructured":"Lundin KE, Wang Q, Hamasy A, Marits P, Uzunel M, Wirta V, et al. Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report. BMC pediatrics. 2018;18(1):285.","journal-title":"BMC pediatrics"},{"issue":"9","key":"2012_CR12","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/jbmr.3173","volume":"32","author":"G Pacheco-Cu\u00e9llar","year":"2017","unstructured":"Pacheco-Cu\u00e9llar G, Gauthier J, D\u00e9silets V, Lachance C, Lemire\u2010Girard M, Rypens F, et al. A novel PGM3 mutation is associated with a severe phenotype of bone marrow failure, severe combined immunodeficiency, skeletal dysplasia, and congenital malformations. Journal of Bone and Mineral Research. 2017;32(9):1853\u20139.","journal-title":"Journal of Bone and Mineral Research"},{"issue":"5","key":"2012_CR13","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s10875-021-00985-w","volume":"41","author":"M Fusaro","year":"2021","unstructured":"Fusaro M, Vincent A, Castelle M, Rosain J, Fournier B, Veiga-da-Cunha M, et al. Two novel homozygous mutations in phosphoglucomutase 3 leading to severe combined immunodeficiency, skeletal dysplasia, and malformations. Journal of clinical immunology. 2021;41(5):958\u201366.","journal-title":"Journal of clinical immunology"},{"issue":"1","key":"2012_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13223-022-00749-0","volume":"18","author":"M Fallahi","year":"2022","unstructured":"Fallahi M, Jamee M, Enayat J, Abdollahimajd F, Mesdaghi M, Khoddami M, et al. Novel PGM3 mutation in two siblings with combined immunodeficiency and childhood bullous pemphigoid: a case report and review of the literature. Allergy, Asthma & Clinical Immunology. 2022;18(1):111.","journal-title":"Allergy, Asthma & Clinical Immunology."},{"issue":"3","key":"2012_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10875-021-01196-z","volume":"42","author":"A Winslow","year":"2022","unstructured":"Winslow A, Jalazo ER, Evans A, Winstead M, Moran T. A De Novo cause of PGM3 deficiency treated with hematopoietic stem cell transplantation. Journal of Clinical Immunology. 2022;42(3):691\u20134.","journal-title":"Journal of Clinical Immunology"},{"key":"2012_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molimm.2017.06.248","volume":"90","author":"L Ben-Khemis","year":"2017","unstructured":"Ben-Khemis L, Mekki N, Ben-Mustapha I, Rouault K, Mellouli F, Khemiri M, et al. A founder mutation underlies a severe form of phosphoglutamase 3 (PGM3) deficiency in Tunisian patients. Molecular immunology. 2017;90:57\u201363.","journal-title":"Molecular immunology"},{"key":"2012_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.108988","volume":"237","author":"A Gharehzadehshirazi","year":"2022","unstructured":"Gharehzadehshirazi A, Amini A, Rezaei N. Hyper IgE syndromes: A clinical approach. Clinical Immunology. 2022;237:108988.","journal-title":"Clinical Immunology"},{"issue":"2","key":"2012_CR18","doi-asserted-by":"publisher","DOI":"10.70962\/jhi.20250176","volume":"2","author":"C Wang","year":"2025","unstructured":"Wang C, Patel M, Urban A, Nelson CG, DiMaggio T, Heller T, et al. Extended clinical phenotypes and long-term outcomes of phosphoglucomutase-3 deficiency. Journal of Human Immunity. 2025;2(2):e20250176.","journal-title":"Journal of Human Immunity"},{"issue":"4","key":"2012_CR19","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.jaci.2018.12.987","volume":"143","author":"M Ben-Ali","year":"2019","unstructured":"Ben-Ali M, Ben-Khemis L, Mekki N, Yaakoubi R, Ouni R, Benabdessalem C, et al. Defective glycosylation leads to defective gp130-dependent STAT3 signaling in PGM3-deficient patients. Journal of Allergy and Clinical Immunology. 2019;143(4):1638-40. e2.","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"2012_CR20","unstructured":"Abinun MAM, Beaussant Cohen S, Buckland M, Bustamante J, Cant AJ, et al. ESID registry - Working definitions for clinical diagnosis of PID. https:\/\/esid.org\/Working\u2010Parties\/Registry\u2010Working\u2010Party\/Diagnosis\u2010crite ria. Accessed 22 Nov 2022. )."},{"issue":"1","key":"2012_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/ped.15082","volume":"64","author":"I Altun","year":"2022","unstructured":"Altun I, Kiykim A, Zubarioglu T, Burtecene N, Hopurcuoglu D, Topcu B, et al. Altered immune response in organic acidemia. Pediatrics International. 2022;64(1):e15082.","journal-title":"Pediatrics International"},{"issue":"5","key":"2012_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R. Fast and accurate long-read alignment with Burrows\u2013Wheeler transform. Bioinformatics. 2010;26(5):589\u201395.","journal-title":"Bioinformatics"},{"key":"2012_CR23","unstructured":"Zhao C, Su K-J, Wu C, Cao X, Sha Q, Li W, et al. Multi-View Variational Autoencoder for Missing Value Imputation in Untargeted Metabolomics. ArXiv. 2024:arXiv: 2310.07990 v2."},{"issue":"16","key":"2012_CR24","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic acids research. 2010;38(16):e164-e.","journal-title":"Nucleic acids research"},{"key":"2012_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","volume":"491","author":"GR Abecasis","year":"2012","unstructured":"1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. An integrated map of genetic variation from 1092 human genomes. Nature. 2012;491:56\u201365. https:\/\/doi.org\/10.1038\/nature11632.","journal-title":"Nature"},{"issue":"W1","key":"2012_CR26","doi-asserted-by":"publisher","first-page":"W452","DOI":"10.1093\/nar\/gks539","volume":"40","author":"N-L Sim","year":"2012","unstructured":"Sim N-L, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic acids research. 2012;40(W1):W452\u20137.","journal-title":"Nucleic acids research"},{"issue":"1","key":"2012_CR27","doi-asserted-by":"publisher","first-page":"7.20. 1","DOI":"10.1002\/0471142905.hg0720s76","volume":"76","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Current protocols in human genetics. 2013;76(1):7.20. 1-7.. 41.","journal-title":"Current protocols in human genetics"},{"issue":"4","key":"2012_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nature methods. 2014;11(4):361\u20132.","journal-title":"Nature methods"},{"issue":"11","key":"2012_CR29","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R, et al. VarSome: the human genomic variant search engine. Bioinformatics. 2019;35(11):1978\u201380.","journal-title":"Bioinformatics."},{"issue":"1","key":"2012_CR30","first-page":"39","volume":"35","author":"TH Mogensen","year":"2016","unstructured":"Mogensen TH. Primary immunodeficiencies with elevated IgE. International reviews of immunology. 2016;35(1):39\u201356.","journal-title":"International reviews of immunology"},{"key":"2012_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1500381","volume":"15","author":"L Yang","year":"2024","unstructured":"Yang L, Zerbato B, Pessina A, Brambilla L, Andreani V, Frey-Jakobs S, et al. PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect. Frontiers in immunology. 2024;15:1500381.","journal-title":"Frontiers in immunology"},{"issue":"1","key":"2012_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev-neuro-071714-034019","volume":"38","author":"HH Freeze","year":"2015","unstructured":"Freeze HH, Eklund EA, Ng BG, Patterson MC. Neurological aspects of human glycosylation disorders. Annual review of neuroscience. 2015;38(1):105\u201325.","journal-title":"Annual review of neuroscience"},{"issue":"3","key":"2012_CR33","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.jaci.2019.11.016","volume":"145","author":"J Verheijen","year":"2019","unstructured":"Verheijen J, Wong SY, Rowe JH, Raymond K, Stoddard J, Delmonte OM, et al. Defining a new immune deficiency syndrome: MAN2B2-CDG. The Journal of allergy and clinical immunology. 2019;145(3):1008.","journal-title":"The Journal of allergy and clinical immunology."},{"issue":"9","key":"2012_CR34","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1084\/jem.20161810","volume":"214","author":"T Schwerd","year":"2017","unstructured":"Schwerd T, Twigg SR, Aschenbrenner D, Manrique S, Miller KA, Taylor IB, et al. A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis. Journal of Experimental Medicine. 2017;214(9):2547\u201362.","journal-title":"Journal of Experimental Medicine"},{"issue":"1","key":"2012_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","volume":"36","author":"SH Ross","year":"2018","unstructured":"Ross SH, Cantrell DA. Signaling and function of interleukin-2 in T lymphocytes. Annual review of immunology. 2018;36(1):411\u201333.","journal-title":"Annual review of immunology"},{"issue":"1","key":"2012_CR36","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/s41467-017-01677-z","volume":"8","author":"J-L Wu","year":"2017","unstructured":"Wu J-L, Chiang M-F, Hsu P-H, Tsai D-Y, Hung K-H, Wang Y-H, et al. O-GlcNAcylation is required for B cell homeostasis and antibody responses. Nature communications. 2017;8(1):1854.","journal-title":"Nature communications."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-026-02012-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02012-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02012-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:05:29Z","timestamp":1781643929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-026-02012-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2012"],"URL":"https:\/\/doi.org\/10.1007\/s10875-026-02012-2","relation":{},"ISSN":["1573-2592"],"issn-type":[{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}